Afleveringen
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This week we have seen a number of positive announcements related to the early clinical and preclinical development of immunotherapies, including an islet cell therapy for diabetes, an antibody-drug conjugate and a CAR-T therapy for multiple myeloma, and a peptide-drug conjugate and a vaccine for head and neck cancers.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
In this podcast we speak to experts from Lonza and Oxford Nanopore about their collaboration to bring direct mRNA sequencing (including N1-Methyl-pseudouridine) to a regulated environment and establish the new gold standard in sequencing technology.
We discuss how nanopore sequencing will be used to perform unbiased identity testing while enabling the simultaneous analyses of multiple critical quality attributes such as integrity (mRNA length and poly-A tail length) and capping.
-
Zijn er afleveringen die ontbreken?
-
The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
Our news round-up at the end of last year focused on drug discovery investment, so it is positive to see that this has also started strong in 2025, with a number of new acquisitions, research partnership agreements and financings to kick off the new year.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This is the latest episode of the free DDW narrated podcast, titled âWhere are the global breakthroughs, opportunities and developments in cancer research?â, which covers three articles written for DDW Volume 24 â Issue 2, Spring 2023 of DDW. They are called: âGlobal breakthroughs in cancer drug discoveryâ, âThe Achillesâ heel of cancerâ, and âImmunotherapy is here to stayâ.
At the time of writing in the first article, AstraZeneca UK had appointed David Brocklehurst as Head of Oncology in the UK. I spoke with him about how AstraZeneca is innovating to displace chemotherapy and research areas of significance.
In the second article, Genoscience Pharmaâs Philippe Halfon and Eric Raymond share their expertise on targeting the recycling of unsustainable production of palmitoylated cancer-associated proteins.
In the third article, I spoke with Frédéric Triebel, the French immunologist/oncologist who is best known for his 1990 discovery of the LAG-3 immune control mechanism. Triebel shares insights from his career, expands on his experience with the company he founded, Immutep, and comments on the future of immuno-oncology.
-
This is the latest episode of the free DDW narrated podcast, titled âInnovative approaches to improving drug discoveryâ, which covers three articles written for DDW Volume 24 â Issue 2, Spring 2023 of DDW. They are called: Post-Covid cognitive impairment: a new target for drug development?, Sitting Down With Dr Harren Jhoti, Astex Pharmaceuticals, and The Nobel Prize winning power of click chemistry.
In the first article, Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne, and Dr Jenny Barnett explore the effects of long Covid symptoms and what the opportunities are for drug developers working to treat post-Covid cognitive impairment.
In the second article, Dr Harren Jhoti speaks to Diana Spencer after receiving his OBE, about his career, the UK life sciences sector, fragment-based drug discovery and what the future holds for the industry.
In the third article, JosĂ© MejĂa Oneto, PhD, Founder and CEO at Shasqi, discusses the potential of chemistry to engineer biology to improve the effectiveness of human therapeutics and revolutionise the treatment of disease.
-
The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
As we approach the end of 2024, itâs great to see that investment in drug discovery is still going strong, with an impressive $300 million raised by AI-focused company SandboxAQ and another significant financing by Ottimo Pharma.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
Itâs been a big week for cell and gene therapies (CGTs) as the first in vivo BCMA CAR-T candidate reaches the clinic and a new discovery could lead to a gene therapy that reverses a significant cause of stillbirth and premature delivery.
You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This episode of the DDW narrated podcast series is titled âNew ways to treat cancerâ, which covers three articles written for DDW Volume 24 â Issue 2, Spring 2023 of DDW. They are called: â3D Genomics and targeted cancer therapiesâ, âDemocratising proteomics for cancer and beyondâ, and Meet the Researcher: John Maherâ
In the first article, Anthony Schmitt, PhD, Senior Vice President, Science at Arima Genomics, discusses the applications of 3D genomics in cancer research.
In the second article, DDW Editor Reece Armstrong speaks to Nautilus Co-Founder and Chief Scientist Parag Mallick, about the companyâs recent collaboration which aims to uncover the proteins that could be behind a rare and fatal childhood cancer.
In the third article, John Maher, Leucid Bio, told me about his work and offers valuable advice to others in this field.
-
The latest episode of the DDW Highlights podcast is now available to listen to. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This weekâs leading news stories all shine a light on innovation within drug discovery, including a potential âbest-in-industryâ weight loss drug, a gold-based compound that shrinks tumours by 82%, and a second-generation CAR-T therapy.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This episode of the DDW narrated podcast series is titled âThe far-reaching impact of drug discovery technologyâ, which covers three articles written for Volume 24 â Issue 2, Spring 2023 of DDW. They are called: âAccelerating time to market through digitalisationâ, âWhy digital biomarkers will power tomorrowâs Alzheimerâs therapiesâ, and âThe path to improved safety of gene-based productsâ.
In the first article, Sascha Fischer Business Development Manager for Automation at Genedata looks at three critical digitalisation components that enable end-to-end lab automation, improve the return on investment (ROI) on instrumentation investments and streamline time-to-market.
In the second article, Rivka Kreitman, CIO of NeuraLight explores the landscape of therapies for Alzheimerâs and explains why digital biomarkers are key to combatting the disease.
In the third article, Kerstin Pohl, Senior Global Marketing Manager, Gene Therapy & Nucleic Acid at SCIEX, looks at the application of liquid chromatography-mass spectrometry for analysing host cell proteins.
-
The latest episode of the DDW Highlights podcast is now available to listen to. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This weekâs leading news stories all feature early-stage clinical trials, including a short interfering RNA for cardiovascular disease, a new type of drug for type 2 diabetes, a gene therapy for Duchenne muscular dystrophy, a T cell therapy for hepatitis B, and a monoclonal antibody to prevent respiratory syncytial virus.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This is the latest episode of the free DDW narrated podcast, titled âExciting start-ups and developments in drug discoveryâ, which covers two articles written for DDW Volume 24 â Issue 1, Winter 2022/2023. They are called: âWhat Lithuania offers life sciences start-upsâ and âAvoiding detection â the cancer cells evading the bodyâs natural defenceâ.
In the first article, DDW Editor Reece Armstrong takes a look at Lithuaniaâs life sciences sector and what it means for start-ups operating in the country.
In the second article, DDW Editor Reece Armstrong explores recent research looking into why cancer cells are so effective at avoiding the bodyâs immune system.
-
The latest episode of the DDW Highlights podcast is now available to listen to and watch below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This weekâs most exciting news stories all represent innovative solutions to the treatment of disease, proving that âthinking outside the boxâ can by the key to success in drug discovery.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
With the Society for Immunotherapy of Cancer (SITC)âŻ2024 taking place in Houston recently, there have been a number of recent announcements regarding the clinical advancement of immunocytokines, METTL3 inhibitors, cancer vaccines, CAR-T therapies and immune checkpoint inhibitors for the treatment of cancer.
You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
This week DDW has reported on significant investment in the development of treatments for neurodegenerative diseases, but also gene therapies for CNS disorders and radioligand-based therapies for cancer.
You can listen here, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
In a week that saw a second monoclonal antibody rejected by UK regulator NICE, antibodies have been high on the news agenda. More positively, a new indication for Fasenra was approved in the EU, researchers found an antibody platform could overcome the challenges of treating mutating viruses, and monoclonal antibodies showed promise in lung cancer and immunoglobulin A nephropathy.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
This is the latest episode of the free DDW narrated podcast, titled "How to streamline regulatory approval", which covers two articles written for Volume 24 â Issue 1, Winter 2022/2023 of DDW. They are called: Quicker time to regulatory submission through improved data management and The three key stages to a successful specialty drug launch.
In the first article, Ken Forman, Senior Director of Product Strategy, IDBS explains how robust digital workflows can reduce errors and time to compile data leading to greater transparency, faster reporting and help biopharmaceutical companies reach regulatory submission faster.
In the second article, Craig Caceci, Managing Director at Terebellum, offers guidance to pharmaceutical companies that are in the position to take their drugs to market.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
With a presidential election just round the corner in the US and a new UK budget on the way, financial support for life sciences is high on the agenda, so the news round-up this week focuses on investment in drug discovery, by private investors, governments and charities.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.
In this episode, Megan Thomas is in conversation with CEO of Oxeia, Dr Michael Wyand, where we talk about Oxeiaâs work; the unmet critical need for concussion drug therapies; the challenges facing them, including in clinical trials and investment; the potential market for concussion drugs, and more.
You can now, and find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
-
The latest episode of the DDW Highlights podcast is now available to listen to below. DDWâs Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.
As we are halfway through Breast Cancer Awareness Month, our news highlights this week focus on studies that could advance the treatment of cancer in the future, including a new understanding of cancer drug resistance, and novel therapeutics like radioimmunotherapy, RBM39 degraders and peptide-drug conjugates.
You can listen below, or find The Drug Discovery World Podcast on Spotify, Google Play and Apple Podcasts.
- Laat meer zien
